Study of Vadadustat in Hemodialysis Patients With Anemia Switching From Epoetin Alfa
Conditions: Anemia; Dialysis-dependent Chronic Kidney Disease Interventions: Drug: Vadadustat; Drug: Epoetin Alfa; Drug: Vadadustat TIW Sponsor: Akebia Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anemia | Dialysis | Epogen | Hemodialysis | Procrit | Research | Study | Urology & Nephrology